Scientific Reports (May 2017)

Functional interaction between FUS and SMN underlies SMA-like splicing changes in wild-type hFUS mice

  • Alessia Mirra,
  • Simona Rossi,
  • Silvia Scaricamazza,
  • Michela Di Salvio,
  • Illari Salvatori,
  • Cristiana Valle,
  • Paola Rusmini,
  • Angelo Poletti,
  • Gianluca Cestra,
  • Maria Teresa Carrì,
  • Mauro Cozzolino

Journal volume & issue
Vol. 7, no. 1
pp. 1 – 14


Read online

Abstract Several of the identified genetic factors in Amyotrophic Lateral Sclerosis (ALS) point to dysfunction in RNA processing as a major pathogenic mechanism. However, whether a precise RNA pathway is particularly affected remains unknown. Evidence suggests that FUS, that is mutated in familial ALS, and SMN, the causative factor in Spinal Muscular Atrophy (SMA), cooperate to the same molecular pathway, i.e. regulation of alternative splicing, and that disturbances in SMN-regulated functions, either caused by depletion of SMN protein (as in the case of SMA) or by pathogenic interactions between FUS and SMN (as in the case of ALS) might be a common theme in both diseases. In this work, we followed these leads and tested their pathogenic relevance in vivo. FUS-associated ALS recapitulates, in transgenic mice, crucial molecular features that characterise mouse models of SMA, including defects in snRNPs distribution and in the alternative splicing of genes important for motor neurons. Notably, altering SMN levels by haploinsufficiency or overexpression does not impact the phenotypes of mouse or Drosophila models of FUS-mediated toxicity. Overall, these findings suggest that FUS and SMN functionally interact and that FUS may act downstream of SMN-regulated snRNP assembly in the regulation of alternative splicing and gene expression.